HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-Methylhistamine → [3-(4Fluorophenyl)(1H-indazol-5-YL)]-N-[2-(1-methylimidazol-5-YL)ethyl]carboxamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-Methylhistamine | HCID 69520 | — |
| Reactant | 1-acetyl-3-(4-fluorophenyl)-1H-indazole-5-carbonyl chloride | HCID 22480227 | — |
| Product | [3-(4Fluorophenyl)(1H-indazol-5-YL)]-N-[2-(1-methylimidazol-5-YL)ethyl]carboxamide | HCID 20789049 | 32% |
Reaction Steps
The product was synthesized as described in Example 109 using 1-acetyl-3-(4-fluorophenyl)-1H-indazole-5-carbonyl chloride (142.5 mg, 0.45 mmol) and 3-methylhistamine 100 mg, 0.5 mmol). The product was purified by semipreparative HPLC (20–80% acetonitrile gradient over 30 minutes at 20 mL/min) to yield the title compound (52 mg, 32% yield). 1H NMR (DMSO-d6) δ 8.85 (s, 1H), 8.5 (s, 1H), 8.05 (m, 2H), 7.9 (d, 1H), 7.7 (d, 1H), 7.4 (m, 3H), 3.9 (s, 3H), 3.6 (m, 2H), 3.0 (m, 2H). ES-MS m/z 364 [M+1]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07208513B2 |
| Source dataset | uspto-grants-2007_04 |
| ORD ID | ord-2b39f30c8cc149df97914d078a0220b2 |
| Source note | uspto-grants-2007_04 |